RAISED LEVEL OF LIPOPROTEIDE(A) AS A PREDICTOR OF CARDIOVASCULAR COMPLICATION POST REVASCULARIZATION OF THE LOWER ExTREMETIES ARTERIES

QR Code

RAISED LEVEL OF LIPOPROTEIDE(A) AS A PREDICTOR OF CARDIOVASCULAR COMPLICATION POST REVASCULARIZATION OF THE LOWER ExTREMETIES ARTERIES

Aim. Lipoproteide (a) (Lpa) is a pathogenetic risk factor of cardiovascular atherosclerotic disease. On the role of Lpa in the development of cardiovascular complications (CVC) after lower limbs arteries revascularization, there is lack of data. The aim of the study was assessment of Lpa relation to...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. A. Tmojan, О I. Afanasieva, A. Е. Zotikov, E. A. Klesareva, M. M. Abdulgamidov, М. V. Ezhov, A. V. Pokrovsky, S. N. Pokrovsky
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-09-01
Series:	Российский кардиологический журнал
Subjects:	lipoproteide (a) apoprotein (a) peripheral atherosclerosis lower extremities atherosclerosis cardiovascular complications
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2726
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
by: E. A. Klesareva, et al.
Published: (2018-09-01)

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)

Inflammation markers in coronary heart disease patients with aortic valve stenosis
by: O. I. Afansieva, et al.
Published: (2018-09-01)

CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE
by: O. I. Afanasieva, et al.
Published: (2016-01-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Clinical role of apolipoproteins A and B
by: G. A. Chumakova, et al.
Published: (2011-12-01)

SUBFRACTIONAL SPECTRUM OF HIGH DENSITY LIPOPROTEIDS IN CORONARY ATHEROSCLEROSIS PATIENTS
by: I. N. Ozerova, et al.
Published: (2015-04-01)

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease
by: Alexandra V. Tyurina, et al.
Published: (2025-06-01)

GENDER SPECIFICS OF SUBFRACTIONAL PLASMA LIPOPROTEIDS DISTRIBUTION
by: I. N. Ozerova, et al.
Published: (2016-08-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Lipoprotein(a) concentration and the blood content of INFγ-producing T-helpers 17 (Th17/1) in males with premature coronary artery disease
by: A. Yu. Filatova, et al.
Published: (2022-07-01)

Features of Prediction of Heart Failure in Patients with Peripheral Atherosclerosis During a Three-Year Prospective Follow-Up
by: N. D. Kobzeva, et al.
Published: (2022-10-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Number of blood neutrophil granulocytes is associated with diffuse coronary involvement in patients with increased lipoprotein (a)
by: A. Yu. Filatova, et al.
Published: (2023-11-01)

HIGH INTENSITY HYPOLIPIDEMIC THERAPY AND DECREASED LEVEL OF LOW DENSITY LIPOPROTEIDES CHOLESTEROL: IS THE APPROACH JUSTIFIED? POINT OF VIEW
by: M. G. Bubnova
Published: (2018-07-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY
by: E. P. Trukhacheva, et al.
Published: (2016-01-01)

OUTPATIENT FOLLOW-UP OF THE LOWER EXTREMITIES ATHEROSCLEROSIS PATIENTS FROM CARDIOLOGIST POINT OF VIEW
by: A. N Sumin, et al.
Published: (2016-12-01)

Annexin A8 deficiency delays atherosclerosis progression
by: Carmen Gutiérrez‐Muñoz, et al.
Published: (2025-01-01)

Abdominal aortic diameter as a predictor of peripheral atherosclerosis progression in 40-64-year-old patients with cardiovascular risk factors
by: V. V. Genkel, et al.
Published: (2023-09-01)

Risk factors of adverse cardiovascular prognosis in patients with peripheral artery disease
by: A. R. Askarov, et al.
Published: (2012-12-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis
by: L. S. Barbarash, et al.
Published: (2019-11-01)

Lipoprotein(a) as underestimated cardiovascular risk factor in Russia. Time to introduce into clinical practice
by: O. I. Afanasyeva, et al.
Published: (2024-10-01)

NOVEL OPPORTUNITIES TO REACH THE TARGET LEVELS OF LOW DENSITY CHOLESTEROL
by: M. V. Ezhov
Published: (2014-08-01)

Factors and mechanisms of arterial hypertension development in patients with atherosclerosis of lower limb arteries
by: E. M. Evsikov, et al.
Published: (2019-03-01)

C-reactive protein: pathogenetic characteristics and possible therapeutic target
by: E. A. Utkina, et al.
Published: (2021-07-01)

THE RELATION OF ATHEROGENIC OXIDATIVE-ANTIOXIDANT SHIFTS IN LOW DENSITY LIPOPROTEIDES WITH ADVERSE LONG-TERM PROGNOSIS IN MALES
by: Yu. I. Ragino, et al.
Published: (2016-12-01)

Subclinical peripheral atherosclerosis in patients with chronic pulmonary disease: the role of psychological distress predisposition
by: A. N. Sumin, et al.
Published: (2013-06-01)

Factors determining the prognosis after elective myocardial revascularization in patients with coronary artery disease with multifocal atherosclerosis
by: M. B. Khakimova, et al.
Published: (2023-11-01)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023-06-01)

Predictors of stable coronary artery disease progression in the post-COVID period.
by: D. A. Derisheva, et al.
Published: (2025-06-01)

Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis
by: Stamatios Lampsas, et al.
Published: (2025-06-01)

POLYCLINICS PHYSICIAN EDUCATION — IN THE CENTER OF A PROBLEMATIC TRIANGLE
by: A. L. Vertkin
Published: (2017-04-01)

Peripheral artery disease In West Africans with diabetes: a risk factor profile analysis
by: Joachim Amoako, et al.
Published: (2025-09-01)

LIPID PROFILE AND GENETIC MARKERS ASSOCIATED WITH THE LEVEL OF OXIDIzED LOW DENSITY LIPOPROTEIDES
by: E. Yu. Khlebus, et al.
Published: (2017-11-01)

SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: O. U. Atkov, et al.
Published: (2015-03-01)